Lonneke M. A. Wijnhoven

Lonneke M. A. Wijnhoven

Auto-generated profile, based on publicly available information

Lonneke M. A. Wijnhoven

Department of Medical Psychology Research Institute for Medical Innovation Radboudumc Nijmegen Nijmegen the Netherlands

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2021 in Psycho-Oncology
Verified
Journal Article
Open access
PDF file
FBFlorie E. Van Beek
Florie E. Van Beek
LWLonneke M. A. Wijnhoven
Lonneke M. A. Wijnhoven
KHKaren Holtmaat
Karen Holtmaat
JCJosé A. E. Custers
José A. E. Custers
JPJudith B. Prins
Judith B. Prins
FJFemke Jansen
Femke Jansen
Objective: This study systematically reviewed the association of psychological problems among cancer patients with healthcare and societal resource use and costs.Methods: PubMed, PsycINFO, and Embase were searched (until 31 January 2021) for studies on psychological symptoms (anxiety, depression, distress, fear of recurrence) or psychiatric disorders (anxiety, depression, adjustment) and healthcare use (e.g., mental, inpatient healthcare), economic losses by patients and family, economic losses in other sectors (e.g., absence from work), and costs. The search, data extraction, and quality assessment were performed by two authors.Results: Of the 4157 identified records, 49 articles were included (psychological symptoms (n = 34), psychiatric disorders (n = 14), both (n = 1)) which focused on healthcare use (n = 36), economic losses by patients and family (n = 5), economic losses in other sectors (n = 8) and/or costs (n = 13). In total, for 12 of the 94 associations strong evidence was found. Psychological symptoms and psychiatric disorders were positively associated with increased healthcare use (mental, primary, inpatient, outpatient healthcare), losses in other sectors (absence from work), and costs (inpatient, outpatient, total healthcare costs). Moderate evidence was found for a positive association between (any) psychiatric disorder and depression disorder with inpatient healthcare and medication use, respectively.Conclusions: Psychological problems in cancer patients are associated with increased healthcare use, healthcare costs and economic losses. Further research is needed on psychological problems in relation to understudied healthcare use or costs categories, productivity losses, and informal care costs.

12 January 2022 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
LWLonneke M. A. Wijnhoven
Lonneke M. A. Wijnhoven
JCJosé A. E. Custers
José A. E. Custers
LKLinda Kwakkenbos
Linda Kwakkenbos
JPJudith B. Prins
Judith B. Prins
Objective: Breast cancer survivors (BCS) may experience problems to adjust to their situation after cancer treatment completion. In case of severe distress, an adjustment disorder (AD) might develop. This study investigates the course of AD symptoms during 1 year and its predictors in BCS up to 5 years post-treatment. Methods: BCS completed the Hospital Anxiety and Depression Scale (HADS) at baseline, 3, 6, and 12 months. HADS total scores were defined as no mental disorder (MD) symptoms (≤ 10), AD symptoms (11–14), and any other MD symptoms (≥ 15). Over the course of four assessments, symptom trajectories were a priori defined as no MD symptoms, AD symptoms, fluctuating AD symptoms below and above cut-offs, or any other MD symptoms. Complementary, latent class growth analysis (LCGA) was used to identify data-driven trajectories. Results: Among 293 BCS with complete data, the majority was classified as no MD symptoms (54.4%), followed by 37.5% in the fluctuating AD symptoms trajectory. Only 1.4% had AD symptoms, and 6.8% had any other MD symptoms. With LCGA (N = 459), three trajectories were found: stable no MD symptoms (58.6%), stable AD symptoms (32.9%), and high increasing any other MD symptoms (8.5%). Compared to BCS with no MD symptoms, BCS with fluctuating AD symptoms or any other MD symptoms were younger, less able to handle daily activities, and showed more social support discrepancy, neuroticism, and less optimism. Conclusions: Results of our study showed that AD symptoms in BCS up to 5 years post-treatment fluctuate over 1 year. It is thus important to appropriately assess AD over the course of 5 years post-treatment as AD symptoms can fluctuate.

23 December 2019 in BMC Psychology
Verified
Journal Article
Open access
PDF file
FBFlorie E. van Beek
Florie E. van Beek
LWLonneke M. A. Wijnhoven
Lonneke M. A. Wijnhoven
FJFemke Jansen
Femke Jansen
JCJosé A. E. Custers
José A. E. Custers
EAEline J. Aukema
Eline J. Aukema
ILIrma M. Verdonck-de Leeuw
Irma M. Verdonck-de Leeuw
Background: Information on the prevalence of adjustment disorders among cancer patients and the value of psychological interventions in this group of patients is limited. This study investigates the prevalence of adjustment disorders among cancer patients as well as the reach, effectiveness, cost-utility and budget impact of a tailored psychological intervention.Method: This study consists of two parts. Part 1 is an observational study among a representative group of mixed cancer patients after cancer treatment on the prevalence of adjustment disorder as well as the uptake (i.e. reach) of psychological treatment. In Part 2, patients diagnosed with an adjustment disorder are invited to participate in a randomized controlled trial. Patients will be randomized to the intervention (access to the tailored psychological intervention) or control group (waitlist period of 6 months). The psychological intervention consists of three modules: one module containing psycho-education (3 sessions, all patients) and two additional modules (maximum of 6 sessions per module) provided as continuum, in case needed. Module 2 and 3 can consist of several evidence-based interventions (e.g. group interventions, mindfulness, eHealth) The primary outcome is psychological distress (HADS). Secondary outcomes are mental adjustment to cancer (MAC) and health-related quality of life (EORTC QLQ-C30). To assess the cost-utility and budget impact, quality of life (EQ-5D-5 L) and costs (iMCQ and iPCQ) will be measured. Measures will be completed at baseline and 3 and 6-months after randomization.Discussion: This study will provide data of the prevalence of adjustment disorders and the reach, effectiveness, cost-utility and budget impact of a tailored psychological intervention.Trial registration: Netherlands Trial Register identifier:NL7763. Registered on 3 June 2019.

1 July 2023 in Journal of Psychosocial Oncology Research and Practice
Verified
Journal Article
Open access
LWLonneke M.A. Wijnhoven
Lonneke M.A. Wijnhoven
LKLinda Kwakkenbos
Linda Kwakkenbos
ILIrma M. Verdonck-De Leeuw
Irma M. Verdonck-De Leeuw
JPJudith B. Prins
Judith B. Prins
JCJosé A.E. Custers
José A.E. Custers
Background: Patients with colorectal cancer (CRC) may experience symptoms of adjustment disorder (AD) after cancer diagnosis and treatment. Time-limited symptoms of AD may become persistent if the stressor or its consequences have not disappeared after 6 months, but evidence on the course of AD symptoms is scarce. This longitudinal observational study investigates the proportion of patients with CRC with time-limited and persistent AD symptoms within the first year after diagnosis, in relation to demographic, clinical, and psychological factors and health-related quality of life (HRQoL). Methods: Informed consent was retrieved from 232 participants, and 194 participants completed questionnaires at baseline, 3, 6, and 12 months postdiagnosis. Hospital Anxiety and Depression Scale total scores (HADS-T) were categorized as indication for no symptoms of a mental disorder (MD) (HADS-T ≤10), AD symptoms (HADS-T 11–14), and other MD symptoms (HADS-T ≥15). Symptom subgroups over time were a priori defined: no MD, time-limited AD, persistent AD, other MD, and fluctuating symptoms. Results: Complete data were available for 81 participants (41.4%). Over time, 38.3% had no MD symptoms, 8.6% had time-limited AD symptoms, 1.2% had persistent AD symptoms, 4.9% had other MD symptoms, and 46.9% had fluctuating symptoms. Participants with AD and fluctuating symptoms reported higher fear of cancer recurrence, lower HRQoL, and higher cancer-specific distress than participants without MD symptoms (P < .5). Conclusions: During the first year after CRC diagnosis, only a small proportion of the patients showed time-limited and persistent AD symptoms and most showed fluctuating symptoms. More prospective research is needed to determine how repeated assessments for elevated AD symptoms relate to an AD diagnosis established with a diagnostic interview.

1 January 2024 in Journal of Psychosocial Oncology Research and Practice
Verified
Journal Article
Open access
LWLonneke M.A. Wijnhoven
Lonneke M.A. Wijnhoven
LZLinda van Zutphen
Linda van Zutphen
JCJosé A. E. Custers
José A. E. Custers
FBFlorie E. van Beek
Florie E. van Beek
KHKaren Holtmaat
Karen Holtmaat
JPJudith B. Prins
Judith B. Prins
Background: The aim of this study was to evaluate the adherence, interrater agreement, and content of a guideline-based semistructured interview for adjustment disorder (AD) in patients with cancer. Methods: In total, 120 AD interviews with patients with cancer were performed by 9 trained psychologists. The interview contained topics related to stressors, resilience, and symptoms and complaints. Audiotaped interviews of 72 patients were available. Adherence to the interview manual was scored by two researchers independently, and the average adherence was calculated per topic. Interrater agreement was calculated using Cohen's Kappa. The content of the interviews was evaluated using thematic analysis of the transcribed interviews of patients with an AD diagnosis. Results: In the interviews, 97% of the topics were covered at least briefly and 78% of all topics were addressed at least adequately. Interviewers asked questions regarding stressors and symptoms and complaints more thoroughly compared with resilience. The interrater agreement regarding the AD diagnosis was moderate (Kappa 0.55). The content analysis showed that stressors and resilience can be additionally specified into physical, psychological, spiritual, and social themes, which are relevant to explore in the context of an AD diagnosis after cancer. Conclusion: The guideline-based interview for AD identifies problems and protective factors with adequate adherence and moderate agreement. A balanced investigation of stressors, resilience, and symptoms is important for optimal clinical decision-making regarding AD in the context of cancer.

15 March 2025 in Psycho-Oncology
Verified
Journal Article
Open access
KHK. Holtmaat
K. Holtmaat
FBF. E. van Beek
F. E. van Beek
LWL. M. A. Wijnhoven
L. M. A. Wijnhoven
JCJosé A. E. Custers
José A. E. Custers
EAE. J. Aukema
E. J. Aukema
FJF. Jansen
F. Jansen
Background: Evidence on the efficacy of psychological interventions targeting cancer patients diagnosed with an adjustment disorder is scarce.Aims: This study aimed to investigate the efficacy and budget impact of a tailored psychological intervention program (AD‐program) targeting cancer patients with adjustment disorder (AD).Methods: Patients (n = 59) were randomised to the intervention or control group. The AD‐program consisted of three modules: psychoeducation (1–4 sessions) and two additional modules (maximum of 6 sessions per module) provided when needed. The primary outcome was psychological distress (HADS). Secondary outcomes were mental adjustment to cancer (MAC) and health‐related quality of life (EORTC QLQ‐C30). Measures were completed at baseline and 3 and 6 months after randomisation. The budget impact analyses were based on the population size, the costs of the AD‐program, and other costs potentially affected by the AD‐program.Results: The mean psychological distress score in the intervention group (n = 33) decreased over time (M = 19.2 at T0, M = 15.6 at T6). This decrease was not significantly different from decrease in the control condition (n = 26, M = 17.5 at T0, M = 15.9 at T6, p > 0.05). Also, there were no significant differences between the two conditions on the secondary outcomes. The budget impact of the AD‐program was estimated at 7–28 million euros per year (to treat 14,430 patients).Conclusions: The effect of the AD‐program was not statistically significant in this RCT. Limitations include that this study was underpowered due to recruitment difficulties during the COVID‐19 pandemic. More research on the efficacy and implementation of the AD‐program is warranted.Trial Registration: Netherlands Trial Register identifier: NL7763. Registered on 3 June 2019